Suchergebnisse - "Zhang, Ricky Ruiqi"

PubPharm (10)

1

Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir : A Phase 2 Open-label Randomized Controlled Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Tam, A. | Zhang, R. | Lung, K. | +23

2

Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant

enthalten in: Frontiers in cellular and infection microbiology | 2023

von Wen, K. | Cai, J. | Fan, X. | +14

3

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Chen, L. | Lu, L. | Choi, C. | +17

4

In-House Immunofluorescence Assay for Detection of SARS-CoV-2 Antigens in Cells from Nasopharyngeal Swabs as a Diagnostic Method for COVID-19

enthalten in: Diagnostics (Basel, Switzerland) | 2021

von Lam, A. | Cai, J. | Leung, K. | +9

5

Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples

enthalten in: Diagnostics (Basel, Switzerland) | 2021

von Chan, K. | Leung, K. | Zhang, R. | +5

6

The impact of spike N501Y mutation on neutralizing activity and RBD binding of SARS-CoV-2 convalescent serum

enthalten in: EBioMedicine | 2021

von Lu, L. | Chu, A. | Zhang, R. | +22

7

A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Hung, I. | Yap, D. | Yip, T. | +11

8

Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury

enthalten in: Circulation journal : official journal of the Japanese Circulation Society | 2020

von Wong, C. | Luk, H. | Lai, W. | +10

9

SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship : a case series

enthalten in: The Lancet. Infectious diseases | 2020

von Hung, I. | Cheng, V. | Li, X. | +29

CommentIn: Lancet Infect Dis. 2020 Sep;20(9):996-998. - PMID 32539989

10

Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19 : an open-label, randomised, phase 2 trial

enthalten in: Lancet (London, England) | 2020

von Hung, I. | Lung, K. | Tso, E. | +41

CommentIn: Lancet. 2020 May 30;395(10238):1670-1671. - PMID 32401712

1
[1]